Compare HRZN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRZN | LAB |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.2M | 347.5M |
| IPO Year | N/A | 2008 |
| Metric | HRZN | LAB |
|---|---|---|
| Price | $4.67 | $0.86 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $6.50 | $1.35 |
| AVG Volume (30 Days) | 636.6K | ★ 5.0M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 33.85% | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | $12.25 | N/A |
| Revenue Next Year | $22.53 | $2.63 |
| P/E Ratio | ★ N/A | $2.61 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.80 | $0.70 |
| 52 Week High | $8.46 | $1.72 |
| Indicator | HRZN | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 57.03 | 48.18 |
| Support Level | $4.56 | $0.79 |
| Resistance Level | $4.74 | $1.01 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 48.44 | 60.02 |
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.